Israel Englander Oramed Pharmaceuticals Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 46,667 shares of ORMP stock, worth $111,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,667
Previous 19,457
139.85%
Holding current value
$111,067
Previous $50,000
126.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ORMP
# of Institutions
63Shares Held
7.4MCall Options Held
4KPut Options Held
2.1K-
Bml Capital Management, LLC Zionsville, IN2.19MShares$5.2 Million3.14% of portfolio
-
Murchinson Ltd. Toronto, A61.71MShares$4.07 Million1.22% of portfolio
-
Boothbay Fund Management, LLC New York, NY828KShares$1.97 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$872,0342.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$689,7310.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $92.4M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...